M

MannKind Corp

D
MNKD
USD
0.055
(0.7891%)
Market Closed
207,890.00
حجم التداول
0.08
الربح لكل سهم
-
العائد الربحي
140.500
P/E
1,931,840,134.93
حجم السوق
اليوم
0.7891%
1 اسبوع
-5.068%
1 شهر
7.252%
6 اشهر
56.459%
12 اشهر
88.338%
بداية السنة
92.730%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
MannKind Corp

Sector:
Healthcare
Industry:
Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
هل تحتاج مساعدة او لديك استفسار؟